Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HTS-4-GBM

Financiado

Cerrado

high throughput screening for high grade glioma

Glioblastoma is the most common and most malignant form of primary brain tumour. It affects both children and adults and remains virtually incurable. As a result, it is a leading cause of cancer-related deaths and more effective t... ver más

31/08/2016

AMU

270K€

Presupuesto del proyecto: 270K€

Líder del proyecto

UNIVERSITE DAIX MARSEILLE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-08-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

AMU

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

3DPD PhD position in commercial environment cancer immunotherapy... 135K€ Cerrado

CAPER/BREAST CANCE CAPER in Invasive Breast Cancer 2M€ Cerrado

Cancer-Drug-Screen High throughput drug screening for identifying personalized... 150K€ Cerrado

BRAINHIB Integrated drug discovery approach to generate brain penetra... 183K€ Cerrado

SAF2011-23870 MEJORA DE LOS PROTOCOLOS PARA DIAGNOSTICO Y SEGUIMIENTO DE R... 327K€ Cerrado

ROUTINE canceR agnOstic immUnoTherapy predIctioN blood-tEst 4M€ Cerrado

Líder del proyecto

UNIVERSITE DAIX MARSEILLE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 270K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Glioblastoma is the most common and most malignant form of primary brain tumour. It affects both children and adults and remains virtually incurable. As a result, it is a leading cause of cancer-related deaths and more effective therapeutic strategies are urgently needed. Herein, I propose to use an innovative methodology combining high-throughput drug screening, pathway analysis and functional genomics to simultaneously develop new treatment modalities and identify novel therapeutic targets / biomarkers for glioblastoma. Using high-throughput screening based on drug repositioning principles, I will first identify already approved drugs that can increase the efficacy of conventional and targeted therapies for glioblastoma. Taking advantage of the first-class and clinically-relevant models of glioblastoma available in the host institution, I will then evaluate the therapeutic potential of the hit compounds in vivo. In parallel, using pathway analysis tools and the known targets of the hit compounds, I will generate a list of genes potentially involved in treatment resistance in glioblastoma. The significance of these genes will then be validated using RNA interference-based high-throughput screening. Finally, the patho-physiological role of the key genes identified and validated by this approach will be investigated by functional genomics and their prognostic and/or predictive value will be evaluated using the unique collection of clinically-annotated samples from glioblastoma patients available in the host institution. Overall, this research project will lead to the identification and pre-clinical validation of innovative treatment combinations for glioblastoma, and the discovery of novel therapeutic targets and biomarkers to be used in future clinical trials. It will thus increase our understanding of the biology and resistance to therapy of glioblastoma and has the potential to significantly impact on clinical practice and patient outcome.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores